PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
about
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
P2860
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
PDCD1 (PD-1) promoter methylat ...... amous cell carcinoma patients.
@en
type
label
PDCD1 (PD-1) promoter methylat ...... amous cell carcinoma patients.
@en
prefLabel
PDCD1 (PD-1) promoter methylat ...... amous cell carcinoma patients.
@en
P2093
P2860
P356
P1433
P1476
PDCD1 (PD-1) promoter methylat ...... amous cell carcinoma patients.
@en
P2093
Andreas Schroeck
Diane Goltz
Dimo Dietrich
Freya Droege
Friederike Schroeck
Friedrich Bootz
Glen Kristiansen
Heidrun Gevensleben
Jennifer Landsberg
Joern Dietrich
P2860
P304
41011-41020
P356
10.18632/ONCOTARGET.17354
P407
P577
2017-04-21T00:00:00Z